STATCenter·
STAT+: Roche expands its Boston footprint with new research center
A gene therapy approved for Sanfilippo syndrome, good and bad news for Xenon Pharma, and more biotech news
Read at STAT →
A gene therapy approved for Sanfilippo syndrome, good and bad news for Xenon Pharma, and more biotech news

<iframe src="https://statesidedaily.com/embed/cluster/cc2afd81637804994cf926be25b27fb2bfcd4018" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: Roche expands its Boston footprint with new research center"></iframe>